BerganKDV Wealth Management’s Merck MRK Stock Holding History

BerganKDV Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.4M	Sell	29,451 -854	-3%	-$97K	0.34%	59
2023 Q1	$3.22M	Sell	30,305 -783	-3%	-$84.5K	0.33%	62
2022 Q4	$3.45M	Sell	31,088 -533	-2%	-$54.5K	0.37%	62
2022 Q3	$2.72M	Buy	31,621 +1,076	+4%	+$96.1K	0.33%	64
2022 Q2	$2.79M	Sell	30,545 -6	-0%	-$532	0.32%	69
2022 Q1	$2.51M	Buy	30,551 +2,332	+8%	+$184K	0.27%	80
2021 Q4	$2.16M	Sell	28,219 -277	-1%	-$22.1K	0.23%	89
2021 Q3	$2.14M	Buy	28,496 +1,674	+6%	+$127K	0.24%	84
2021 Q2	$2.09M	Sell	26,822 -596	-2%	-$44.3K	0.25%	81
2021 Q1	$2.02M	Buy	27,418 +17,454	+175%	+$1.29M	0.26%	76
2020 Q4	$778K	Buy	9,964 +439	+5%	+$33.6K	0.11%	119
2020 Q3	$754K	Buy	9,525 +80	+0.8%	+$6.27K	0.12%	122
2020 Q2	$697K	Sell	9,445 -406	-4%	-$30.6K	0.12%	122
2020 Q1	$723K	Buy	9,851 +4,558	+86%	+$358K	0.15%	110
2019 Q4	$459K	Buy	5,293 +1,049	+25%	+$86.2K	0.08%	155
2019 Q3	$341K	Sell	4,244 -863	-17%	-$69.2K	0.07%	163
2019 Q2	$409K	Buy	5,107 +24	+0.5%	+$1.84K	0.08%	154
2019 Q1	$403K	Sell	5,083 -14,044	-73%	-$1.05M	0.08%	145
2018 Q4	$1.4M	Buy	19,127 +481	+3%	+$34K	0.33%	62
2018 Q3	$1.26M	Sell	18,646 -459	-2%	-$29.2K	0.27%	70
2018 Q2	$1.11M	Buy	19,105 +1,366	+8%	+$77.1K	0.25%	73
2018 Q1	$922K	Buy	17,739 +694	+4%	+$37.5K	0.25%	84
2017 Q4	$915K	Buy	17,045 +1,217	+8%	+$67.5K	0.22%	91
2017 Q3	$967K	Buy	15,828 +362	+2%	+$21.9K	0.24%	80
2017 Q2	$946K	Buy	15,466 +852	+6%	+$51.9K	0.27%	68
2017 Q1	$886K	Buy	14,614 +442	+3%	+$26.8K	0.26%	73
2016 Q4	$796K	Sell	14,172 -671	-5%	-$39.3K	0.27%	74
2016 Q3	$884K	Sell	14,843 -923	-6%	-$54K	0.31%	60
2016 Q2	$867K	Sell	15,766 -1,179	-7%	-$62.7K	0.37%	58
2016 Q1	$856K	Buy	+16,945	New	+$830K	0.51%	57

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BerganKDV Wealth Management's MRK Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Merck (MRK) stake by 2.8% in Q2 2023, selling an estimated $97K and leaving 29,451 shares worth $3.4M. The position accounts for 0.34% of the portfolio, ranked #59.

BerganKDV Wealth Management first reported a position in MRK in Q1 2016 and has held it in 30 quarters since. The position peaked at $3.45M in Q4 2022. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

BerganKDV Wealth Management held 29,451 shares of Merck worth $3.4M as of Q2 2023.
BerganKDV Wealth Management sold 854 Merck shares in Q2 2023, an estimated $97K.
Merck made up 0.34% of BerganKDV Wealth Management's portfolio in Q2 2023, its #59 holding.
BerganKDV Wealth Management first reported a position in Merck in Q1 2016 and has held it in 30 quarters since.
BerganKDV Wealth Management's Merck position peaked at $3.45M in Q4 2022.
3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.